Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Horwich, C Parker, T De Reijke… - Annals of …, 2013 - annalsofoncology.org
The age-standardised incidence of prostate cancer in the European Union (EU) was 65/100
000 men in 2008, ranging in different member states from 18 per 100 000 in Greece to 126
per 100 000 in Ireland depending predominantly on the prevalence of prostate-specific
antigen (PSA) screening [1]. Agestandardised mortality rates are predominantly between 15
and 37 per 100 000 [2]. It is the most common cancer in men with an estimated 382 000
cases occurring during 2008 in Europe. The mortality in the EU is 30.6/100 000 men/year …
000 men in 2008, ranging in different member states from 18 per 100 000 in Greece to 126
per 100 000 in Ireland depending predominantly on the prevalence of prostate-specific
antigen (PSA) screening [1]. Agestandardised mortality rates are predominantly between 15
and 37 per 100 000 [2]. It is the most common cancer in men with an estimated 382 000
cases occurring during 2008 in Europe. The mortality in the EU is 30.6/100 000 men/year …